insulin drugs glp 1 receptor agaonist market GLP-1 Agonist Growth Analysis GLP-1 Receptor Agonists Obesity Drugs
Description
GLP-1RAs significantly increased occurrence of diarrhea (OR: 2.18), hypoglycemia (OR: 3.10), vomiting (OR: 8.22), and nausea (OR: 4.41)
The drugs were developed and initially approved to treat type 2 diabetes, but stronger doses were found to help people effectively lose weight
This allows the active compound to be absorbed into the bloodstream with near-perfect efficiency
Compounded versions of both medications cost significantly less, often $100 to $400 per month depending on the pharmacy and dose
Here's How Weight-Loss
Brock, Kristain
